• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
GBI Entitlement Offer Shortfall Notice - AmendedPRICE SENSITIVE27/03/19
GBI Entitlement Offer Shortfall NoticePRICE SENSITIVE25/03/19
GBI December 2018 Appendix 4CPRICE SENSITIVE01/02/19
GBI Entitlement Offer to raise up to $11.45 MillionPRICE SENSITIVE31/01/19
GBI Prospectus - Non-renounceable rights issuePRICE SENSITIVE31/01/19
GBI Receipt of R&D Tax RebatePRICE SENSITIVE17/01/19
GBI Business Update and September 2018 Appendix 4CPRICE SENSITIVE01/11/18
GBI 30 June 2018 Appendix 4E - Preliminary Final ReportPRICE SENSITIVE03/09/18
GBI Suspension Announcement - System UpgradePRICE SENSITIVE06/08/18
GBI Business Update and June 2018 Appendix 4CPRICE SENSITIVE31/07/18
GBI SuspensionPRICE SENSITIVE04/07/18 download Created with Sketch. 546.43KB
GBI Trading HaltPRICE SENSITIVE02/07/18 download Created with Sketch. 452.79KB
GBI Beckman Coulter Distribution AgreementPRICE SENSITIVE08/05/18
GBI Business Update and March 2018 Appendix 4CPRICE SENSITIVE01/05/18
GBI Final Agreements to Variation of Existing Convertible NotesPRICE SENSITIVE18/04/18
GBI Variation of Existing Series B Convertible NotesPRICE SENSITIVE16/04/18
GBI December 2017 Appendix 4D and Half Year Financial ReportPRICE SENSITIVE28/02/18
GBI Global IVD Partnership UpdatePRICE SENSITIVE16/02/18
GBI Business Update and December 2017 Appendix 4CPRICE SENSITIVE31/01/18
GBI Reinstatement to Official QuotationPRICE SENSITIVE06/12/17
GBI Beckman Coulter Co-marketing PartnershipPRICE SENSITIVE06/12/17
GBI Voluntary SuspensionPRICE SENSITIVE29/11/17
GBI Trading HaltPRICE SENSITIVE27/11/17
GBI Genera Receives R&D Tax RebatePRICE SENSITIVE20/11/17
GBI Business Update and September 2017 Appendix 4CPRICE SENSITIVE01/11/17
GBI 30 June 2017 Appendix 4E - Preliminary Final ReportPRICE SENSITIVE31/08/17
GBI Business Update and June 2017 Appendix 4CPRICE SENSITIVE31/07/17
GBI Variation of Existing Series B Convertible NotesPRICE SENSITIVE03/07/17
GBI Business Update and March 2017 Appendix 4CPRICE SENSITIVE01/05/17
GBI Variation of Existing Series B Convertible NotesPRICE SENSITIVE03/04/17
GBI Appendix 4D and Half Year Financial ReportPRICE SENSITIVE28/02/17
GBI Business Update and December 2016 Appendix 4CPRICE SENSITIVE31/01/17
GBI Agreement to Variation of Existing Mezzanine Debt FacilityPRICE SENSITIVE30/12/16
GBI Agreement to Variation of Existing Series B NotesPRICE SENSITIVE29/12/16
GBI Proposed Amendments to Existing Series B Convertible NotesPRICE SENSITIVE13/12/16
GBI Genera Receives R&D Tax RebatePRICE SENSITIVE21/11/16
GBI Genera anticipates to receive $752k R&D rebatePRICE SENSITIVE15/11/16
GBI Genera Lodges Application for PapType Medicare BenefitsPRICE SENSITIVE11/11/16
GBI Business Update and September 2016 Appendix 4C-GBI.AX PRICE SENSITIVE01/11/16
GBI September 2016 Appendix 4C-GBI.AX PRICE SENSITIVE01/11/16
GBI Data from US based Screening population-GBI.AX PRICE SENSITIVE03/10/16
GBI 30 June 2016 Appendix 4E - Preliminary Final Report-GBI.AX PRICE SENSITIVE31/08/16
GBI Business Update and June 2016 Appendix 4C-GBI.AX PRICE SENSITIVE29/07/16
GBI Indian Market Update and Regulatory Approval-GBI.AX PRICE SENSITIVE21/06/16
GBI Business Update and March 2016 Appendix 4C-GBI.AX PRICE SENSITIVE28/04/16
GBI Appendix 4D and Half Year Financial ReportPRICE SENSITIVE29/02/16
GBI Business Update and December 2015 Appendix 4CPRICE SENSITIVE29/01/16
GBI Business Update and September 2015 Appendix 4CPRICE SENSITIVE30/10/15
GBI 2015 Appendix 4E - Preliminary final reportPRICE SENSITIVE31/08/15
GBI Genera Receives 6,000 Patient Study Clinical DataPRICE SENSITIVE07/08/15
GBI Business Update and June 2015 Appendix 4CPRICE SENSITIVE31/07/15
GBI Indian market launch of AmpaSand assaysPRICE SENSITIVE17/07/15
GBI Business Update and March 2015 Appendix 4CPRICE SENSITIVE30/04/15
GBI CE MARK of PapType and RTI-plex MDx ASSAYSPRICE SENSITIVE08/04/15
GBI ARTG ListingsPRICE SENSITIVE11/03/15
GBI TGA Issues Conformity Assessment CertificatePRICE SENSITIVE05/03/15
GBI Placement of Final Tranche of Unlisted Convertible NotesPRICE SENSITIVE02/03/15
GBI Appendix 4D and Half Year Financial ReportPRICE SENSITIVE27/02/15
GBI Appendix 4C - quarterlyPRICE SENSITIVE30/01/15
GBI Reinstatement to Official QuotationPRICE SENSITIVE19/12/14
GBI Placement of Unlisted Convertible NotesPRICE SENSITIVE19/12/14
GBI Suspension from Official QuotationPRICE SENSITIVE12/12/14
GBI Trading HaltPRICE SENSITIVE10/12/14
GBI Response to Appendix 4C QueryPRICE SENSITIVE01/12/14
GBI Appendix 4C - quarterlyPRICE SENSITIVE31/10/14
GBI Beckman Coulter SCC and CEO AppointmentPRICE SENSITIVE02/10/14
GBI Genera Lodges TGA ApplicationPRICE SENSITIVE03/09/14
GBI 2014 Appendix 4E and Annual ReportPRICE SENSITIVE01/09/14
GBI Strategic Commercial AlliancePRICE SENSITIVE18/08/14
GBI Appendix 4C - quarterlyPRICE SENSITIVE31/07/14
GBI Strategic Review OutcomePRICE SENSITIVE30/06/14
GBI Health Canada approves HPV test as Primary Screening ToolPRICE SENSITIVE16/06/14
GBI Response to ASX Price QueryPRICE SENSITIVE12/06/14
GBIPlacement and Proposed Spin-Out of NextGen Q-Sand AssetsPRICE SENSITIVE19/05/14
GBIResponse to ASX Price QueryPRICE SENSITIVE15/05/14
GBIAppendix 4C - quarterlyPRICE SENSITIVE30/04/14
GBIAustralian MSAC recommends HPV testing to replace PapPRICE SENSITIVE29/04/14
GBIFDA Advisory Committee DecisionPRICE SENSITIVE17/03/14
GBIAppendix 4D and Half Year Financial ReportPRICE SENSITIVE28/02/14
GBIAppendix 4C - quarterlyPRICE SENSITIVE31/01/14
GBIAppendix 4C - quarterlyPRICE SENSITIVE31/10/13
GBIPreliminary Final ReportPRICE SENSITIVE30/08/13
GBIResponse to ASX Query - Appendix 4CPRICE SENSITIVE13/08/13
GBIAppendix 4C - quarterlyPRICE SENSITIVE31/07/13
GBICapital Raising and Business UpdatePRICE SENSITIVE17/07/13
GBIReinstatement to Official QuotationPRICE SENSITIVE17/07/13
GBISuspension from Official QuotationPRICE SENSITIVE10/07/13
GBITrading HaltPRICE SENSITIVE08/07/13
GBIBusiness UpdatePRICE SENSITIVE01/05/13
GBIAppendix 4C - quarterlyPRICE SENSITIVE30/04/13
GBIAppendix 4D and Half Year Financial ReportPRICE SENSITIVE28/02/13
GBIAppendix 4C - quarterly & Business UpdatePRICE SENSITIVE31/01/13
GBIShare Placement, Company Secretary changePRICE SENSITIVE18/12/12
GBIAGM - Chairman's Address to ShareholdersPRICE SENSITIVE22/11/12
GBIAppendix 4C - quarterly & Business UpdatePRICE SENSITIVE30/10/12
GBIPreliminary Final ReportPRICE SENSITIVE28/08/12
GBIAppendix 4C - quarterly & Business UpdatePRICE SENSITIVE31/07/12
GBICommercial Evaluation Agreement with Brazilian Path LabPRICE SENSITIVE06/06/12
GBIBusiness Update and Share Purchase Plan extensionPRICE SENSITIVE25/05/12
GBIAppendix 4C - quarterly, Share Purchase Plan announcedPRICE SENSITIVE30/04/12
GBI Entitlement Offer Shortfall Notice - Amended
27/03/19PRICE SENSITIVE
GBI Entitlement Offer Shortfall Notice
25/03/19PRICE SENSITIVE
GBI December 2018 Appendix 4C
01/02/19PRICE SENSITIVE
GBI Entitlement Offer to raise up to $11.45 Million
31/01/19PRICE SENSITIVE
GBI Prospectus - Non-renounceable rights issue
31/01/19PRICE SENSITIVE
GBI Receipt of R&D Tax Rebate
17/01/19PRICE SENSITIVE
GBI Business Update and September 2018 Appendix 4C
01/11/18PRICE SENSITIVE
GBI 30 June 2018 Appendix 4E - Preliminary Final Report
03/09/18PRICE SENSITIVE
GBI Suspension Announcement - System Upgrade
06/08/18PRICE SENSITIVE
GBI Business Update and June 2018 Appendix 4C
31/07/18PRICE SENSITIVE
GBI Suspension
04/07/18PRICE SENSITIVE download Created with Sketch. 546.43KB
GBI Trading Halt
02/07/18PRICE SENSITIVE download Created with Sketch. 452.79KB
GBI Beckman Coulter Distribution Agreement
08/05/18PRICE SENSITIVE
GBI Business Update and March 2018 Appendix 4C
01/05/18PRICE SENSITIVE
GBI Final Agreements to Variation of Existing Convertible Notes
18/04/18PRICE SENSITIVE
GBI Variation of Existing Series B Convertible Notes
16/04/18PRICE SENSITIVE
GBI December 2017 Appendix 4D and Half Year Financial Report
28/02/18PRICE SENSITIVE
GBI Global IVD Partnership Update
16/02/18PRICE SENSITIVE
GBI Business Update and December 2017 Appendix 4C
31/01/18PRICE SENSITIVE
GBI Reinstatement to Official Quotation
06/12/17PRICE SENSITIVE
GBI Beckman Coulter Co-marketing Partnership
06/12/17PRICE SENSITIVE
GBI Voluntary Suspension
29/11/17PRICE SENSITIVE
GBI Trading Halt
27/11/17PRICE SENSITIVE
GBI Genera Receives R&D Tax Rebate
20/11/17PRICE SENSITIVE
GBI Business Update and September 2017 Appendix 4C
01/11/17PRICE SENSITIVE
GBI 30 June 2017 Appendix 4E - Preliminary Final Report
31/08/17PRICE SENSITIVE
GBI Business Update and June 2017 Appendix 4C
31/07/17PRICE SENSITIVE
GBI Variation of Existing Series B Convertible Notes
03/07/17PRICE SENSITIVE
GBI Business Update and March 2017 Appendix 4C
01/05/17PRICE SENSITIVE
GBI Variation of Existing Series B Convertible Notes
03/04/17PRICE SENSITIVE
GBI Appendix 4D and Half Year Financial Report
28/02/17PRICE SENSITIVE
GBI Business Update and December 2016 Appendix 4C
31/01/17PRICE SENSITIVE
GBI Agreement to Variation of Existing Mezzanine Debt Facility
30/12/16PRICE SENSITIVE
GBI Agreement to Variation of Existing Series B Notes
29/12/16PRICE SENSITIVE
GBI Proposed Amendments to Existing Series B Convertible Notes
13/12/16PRICE SENSITIVE
GBI Genera Receives R&D Tax Rebate
21/11/16PRICE SENSITIVE
GBI Genera anticipates to receive $752k R&D rebate
15/11/16PRICE SENSITIVE
GBI Genera Lodges Application for PapType Medicare Benefits
11/11/16PRICE SENSITIVE
GBI Business Update and September 2016 Appendix 4C-GBI.AX
01/11/16PRICE SENSITIVE
GBI September 2016 Appendix 4C-GBI.AX
01/11/16PRICE SENSITIVE
GBI Data from US based Screening population-GBI.AX
03/10/16PRICE SENSITIVE
GBI 30 June 2016 Appendix 4E - Preliminary Final Report-GBI.AX
31/08/16PRICE SENSITIVE
GBI Business Update and June 2016 Appendix 4C-GBI.AX
29/07/16PRICE SENSITIVE
GBI Indian Market Update and Regulatory Approval-GBI.AX
21/06/16PRICE SENSITIVE
GBI Business Update and March 2016 Appendix 4C-GBI.AX
28/04/16PRICE SENSITIVE
GBI Appendix 4D and Half Year Financial Report
29/02/16PRICE SENSITIVE
GBI Business Update and December 2015 Appendix 4C
29/01/16PRICE SENSITIVE
GBI Business Update and September 2015 Appendix 4C
30/10/15PRICE SENSITIVE
GBI 2015 Appendix 4E - Preliminary final report
31/08/15PRICE SENSITIVE
GBI Genera Receives 6,000 Patient Study Clinical Data
07/08/15PRICE SENSITIVE
GBI Business Update and June 2015 Appendix 4C
31/07/15PRICE SENSITIVE
GBI Indian market launch of AmpaSand assays
17/07/15PRICE SENSITIVE
GBI Business Update and March 2015 Appendix 4C
30/04/15PRICE SENSITIVE
GBI CE MARK of PapType and RTI-plex MDx ASSAYS
08/04/15PRICE SENSITIVE
GBI ARTG Listings
11/03/15PRICE SENSITIVE
GBI TGA Issues Conformity Assessment Certificate
05/03/15PRICE SENSITIVE
GBI Placement of Final Tranche of Unlisted Convertible Notes
02/03/15PRICE SENSITIVE
GBI Appendix 4D and Half Year Financial Report
27/02/15PRICE SENSITIVE
GBI Appendix 4C - quarterly
30/01/15PRICE SENSITIVE
GBI Reinstatement to Official Quotation
19/12/14PRICE SENSITIVE
GBI Placement of Unlisted Convertible Notes
19/12/14PRICE SENSITIVE
GBI Suspension from Official Quotation
12/12/14PRICE SENSITIVE
GBI Trading Halt
10/12/14PRICE SENSITIVE
GBI Response to Appendix 4C Query
01/12/14PRICE SENSITIVE
GBI Appendix 4C - quarterly
31/10/14PRICE SENSITIVE
GBI Beckman Coulter SCC and CEO Appointment
02/10/14PRICE SENSITIVE
GBI Genera Lodges TGA Application
03/09/14PRICE SENSITIVE
GBI 2014 Appendix 4E and Annual Report
01/09/14PRICE SENSITIVE
GBI Strategic Commercial Alliance
18/08/14PRICE SENSITIVE
GBI Appendix 4C - quarterly
31/07/14PRICE SENSITIVE
GBI Strategic Review Outcome
30/06/14PRICE SENSITIVE
GBI Health Canada approves HPV test as Primary Screening Tool
16/06/14PRICE SENSITIVE
GBI Response to ASX Price Query
12/06/14PRICE SENSITIVE
GBIPlacement and Proposed Spin-Out of NextGen Q-Sand Assets
19/05/14PRICE SENSITIVE
GBIResponse to ASX Price Query
15/05/14PRICE SENSITIVE
GBIAppendix 4C - quarterly
30/04/14PRICE SENSITIVE
GBIAustralian MSAC recommends HPV testing to replace Pap
29/04/14PRICE SENSITIVE
GBIFDA Advisory Committee Decision
17/03/14PRICE SENSITIVE
GBIAppendix 4D and Half Year Financial Report
28/02/14PRICE SENSITIVE
GBIAppendix 4C - quarterly
31/01/14PRICE SENSITIVE
GBIAppendix 4C - quarterly
31/10/13PRICE SENSITIVE
GBIPreliminary Final Report
30/08/13PRICE SENSITIVE
GBIResponse to ASX Query - Appendix 4C
13/08/13PRICE SENSITIVE
GBIAppendix 4C - quarterly
31/07/13PRICE SENSITIVE
GBICapital Raising and Business Update
17/07/13PRICE SENSITIVE
GBIReinstatement to Official Quotation
17/07/13PRICE SENSITIVE
GBISuspension from Official Quotation
10/07/13PRICE SENSITIVE
GBITrading Halt
08/07/13PRICE SENSITIVE
GBIBusiness Update
01/05/13PRICE SENSITIVE
GBIAppendix 4C - quarterly
30/04/13PRICE SENSITIVE
GBIAppendix 4D and Half Year Financial Report
28/02/13PRICE SENSITIVE
GBIAppendix 4C - quarterly & Business Update
31/01/13PRICE SENSITIVE
GBIShare Placement, Company Secretary change
18/12/12PRICE SENSITIVE
GBIAGM - Chairman's Address to Shareholders
22/11/12PRICE SENSITIVE
GBIAppendix 4C - quarterly & Business Update
30/10/12PRICE SENSITIVE
GBIPreliminary Final Report
28/08/12PRICE SENSITIVE
GBIAppendix 4C - quarterly & Business Update
31/07/12PRICE SENSITIVE
GBICommercial Evaluation Agreement with Brazilian Path Lab
06/06/12PRICE SENSITIVE
GBIBusiness Update and Share Purchase Plan extension
25/05/12PRICE SENSITIVE
GBIAppendix 4C - quarterly, Share Purchase Plan announced
30/04/12PRICE SENSITIVE
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.